PHC Holdings Corporation (TYO:6523)

Revenue by Product

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Diagnostic and Life Sciences	130.92B
Diagnostic and Life Sciences Growth	20.06%
Healthcare Solutions	128.31B
Healthcare Solutions Growth	-3.82%
Diabetes Management	98.69B
Diabetes Management Growth	-9.52%
Reconciling Items	3.67B
Reconciling Items Growth	55.07%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Japan	156.25B
Japan Growth	3.82%
United States	66.33B
United States Growth	4.79%
Europe	64.76B
Europe Growth	-0.88%
Germany	19.42B
Germany Growth	-5.19%
Canada	12.68B
Canada Growth	4.90%
Other	42.16B
Other Growth	-0.11%